Abstract
Embolization of arteriovenous malformations (AVMs) with acrylates can play an important role in treating these complex lesions. Embolization can be performed with an acceptable safety profile when utilizing proper planning and technique. Heterogeneity among these lesions and treatment decisions and techniques vary dramatically between treating physicians and medical centers. Reported general complication rates vary from 1 to 16%, with permanent morbidity rates of 0.4–12.5% and mortality rates of 0.4–11% [1–21]. Within these reports, rates of ischemic complications range from 0.7 to12.5% [2, 7, 20, 22]. Reported hemorrhage rates range from 2 to 15% [2, 7, 14, 20, 22, 23]. These publications reflect large case series employing different embolic agents, including acrylates, and they reflect a mix of modern and discontinued techniques with higher rates of complication compared to current methods [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Debrun G, Vinuela F, Fox A, Drake CG. Embolization of cerebral arteriovenous malformations with bucrylate. J Neurosurg. 1982;56(5):615–27.
Deruty R, Pelissou-Guyotat I, Amat D, et al. Complications after multidisciplinary treatment of cerebral arteriovenous malformations. Acta Neurochir. 1996;138(2):119–31.
Frizzel RT, Fisher WS III. Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery. 1995;37(6):1031–9. Discussion 1039–1040.
Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg. 1996;85(1):19–28.
Hartmann A, Mast H, Mohr JP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke. 1998;29(5):931–4.
Hartmann A, Mast H, Mohr JP, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005;36(11):2431–5.
Jafar JJ, Davis AJ, Berenstein A, Choi IS, Kupersmith MJ. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg. 1993;78(1):60–9.
Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Vinuela F. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery. 2001;48(5):984–95. Discussion 995–987.
Jayaraman MV, McTaggart RA, Sachs GM, Doberstein CE. Cerebellar pial arteriovenous malformations presenting with medullary venous hypertension: imaging and endovascular treatment. J NeuroInterv Surg. 2010;2(1):38–40.
Lasjaunias P, Manelfe C, Chiu M. Angiographic architecture of intracranial vascular malformations and fistulas—pretherapeutic aspects. Neurosurg Rev. 1986;9(4):253–63.
Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery. 2006;58(4):602–11. Discussion 602–611.
Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P. Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients. Neurosurgery. 2000;46(4):793–800. Discussion 800–792.
Meisel HJ, Mansmann U, Alvarez H, Rodesch G, Brock M, Lasjaunias P. Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir. 2002;144(9):879–87. Discussion 888.
Picard L, Da Costa E, Anxionnat R, et al. Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate. J Neuroradiol. 2001;28(3):147–65.
Picard L, Moret J, Lepoire J, et al. Endovascular treatment of intracerebral arteriovenous angiomas. Technique, indications and results. J Neuroradiol. 1984;11(1):9–28.
Steiger HJ, Bruckmann H, Mayer T, Schmid-Elsaesser R, Zausinger S. Congested residual nidus after preoperative intranidal embolization in midsize cerebral arteriovenous malformations of 3-6 cm in diameter. Acta Neurochir. 2004;146(7):649–57.
Taylor CL, Dutton K, Rappard G, et al. Complications of preoperative embolization of cerebral arteriovenous malformations. J Neurosurg. 2004;100(5):810–2.
Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg. 1991;75(6):856–64.
Wikholm G, Lundqvist C, Svendsen P. Embolization of cerebral arteriovenous malformations: part I—technique, morphology, and complications. Neurosurgery. 1996;39(3):448–57. Discussion 457–449.
Jayaraman MV, Marcellus ML, Do HM, et al. Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke. 2007;38(2):325–9.
van Beijnum J, van der Worp HB, Buis DR, et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA. 2011;306(18):2011–9.
Lv X, Wu Z, Jiang C, et al. Complication risk of endovascular embolization for cerebral arteriovenous malformation. Eur J Radiol. 2011;80(3):776–9.
Iwama T, Yoshimura K, Keller E, et al. Emergency craniotomy for intraparenchymal massive hematoma after embolization of supratentorial arteriovenous malformations. Neurosurgery. 2003;53(6):1251–8. Discussion 1258–1260.
Alexander MD, Cooke DL, Nelson J, et al. Association between venous angioarchitectural features of sporadic brain arteriovenous malformations and intracranial hemorrhage. AJNR Am J Neuroradiol. 2015;36(5):949–52.
Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg. 2013;118(2):437–43.
Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL, Coinvestigators M. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology. 2014;83(7):590–7.
Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614–21.
Heit JJ, Faisal AG, Telischak NA, Choudhri O, Do HM. Headway Duo microcatheter for cerebral arteriovenous malformation embolization with n-BCA. J Neurointerv Surg. 2016;8(11):1181–5.
Katsaridis V, Papagiannaki C, Aimar E. Embolization of brain arteriovenous malformations for cure: because we could and because we should. AJNR Am J Neuroradiol. 2009;30(5):e67. Author reply e68.
Lv X, Wu Z, Jiang C, et al. Endovascular treatment accounts for a change in brain arteriovenous malformation natural history risk. Interv Neuroradiol. 2010;16(2):127–32.
Natarajan SK, Born D, Ghodke B, Britz GW, Sekhar LN. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation. J Neurosurg. 2009;111(1):105–13.
Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (onyx). AJNR Am J Neuroradiol. 2009;30(1):99–106.
Stefani MA, Porter PJ, terBrugge KG, Montanera W, Willinsky RA, Wallace MC. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke. 2002;33(5):1220–4.
van Rooij WJ, Sluzewski M, Beute GN. Brain AVM embolization with onyx. AJNR Am J Neuroradiol. 2007;28(1):172–7. Discussion 178.
Weber W, Kis B, Siekmann R, Kuehne D. Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol. 2007;28(2):371–7.
Halbach VV, Higashida RT, Dowd CF, Barnwell SL, Hieshima GB. Management of vascular perforations that occur during neurointerventional procedures. AJNR Am J Neuroradiol. 1991;12(2):319–27.
Sinha PK, Neema PK, Rathod RC. Anesthesia and intracranial arteriovenous malformation. Neurol India. 2004;52(2):163–70.
al-Rodhan NR, Sundt TM Jr, Piepgras DG, Nichols DA, Rufenacht D, Stevens LN. Occlusive hyperemia: a theory for the hemodynamic complications following resection of intracerebral arteriovenous malformations. J Neurosurg. 1993;78(2):167–75.
Miyasaka Y, Yada K, Ohwada T, et al. Hemorrhagic venous infarction after excision of an arteriovenous malformation: case report. Neurosurgery. 1991;29(2):265–8.
Nornes H, Grip A. Hemodynamic aspects of cerebral arteriovenous malformations. J Neurosurg. 1980;53(4):456–64.
Wilson CB, Hieshima G. Occlusive hyperemia: a new way to think about an old problem. J Neurosurg. 1993;78(2):165–6.
Barnett GH, Little JR, Ebrahim ZY, Jones SC, Friel HT. Cerebral circulation during arteriovenous malformation operation. Neurosurgery. 1987;20(6):836–42.
Day AL, Friedman WA, Sypert GW, Mickle JP. Successful treatment of the normal perfusion pressure breakthrough syndrome. Neurosurgery. 1982;11(5):625–30.
Leblanc R, Little JR. Hemodynamics of arteriovenous malformations. Clin Neurosurg. 1990;36:299–317.
Nagao S, Ueta K, Mino S, et al. Monitoring of cortical blood flow during excision of arteriovenous malformation by thermal diffusion method. Surg Neurol. 1989;32(2):137–43.
Spetzler RF, Wilson CB, Weinstein P, Mehdorn M, Townsend J, Telles D. Normal perfusion pressure breakthrough theory. Clin Neurosurg. 1978;25:651–72.
Albert P. Personal experience in the treatment of 178 cases of arteriovenous malformations of the brain. Acta Neurochir. 1982;61(1–3):207–26.
Albert P, Salgado H, Polaina M, Trujillo F, Ponce de Leon A, Durand F. A study on the venous drainage of 150 cerebral arteriovenous malformations as related to haemorrhagic risks and size of the lesion. Acta Neurochir. 1990;103(1–2):30–4.
Alexander MD, Cooke DL, Hallam DK, Kim H, Hetts SW, Ghodke BV. Less can be more: targeted embolization of aneurysms associated with arteriovenous malformations unsuitable for surgical resection. Interv Neuroradiol. 2016;22(4):445–51.
Bai J, Dou CW, Wang YJ, et al. Correlations of angio-architectural factors with cerebral arteriovenous malformation hemorrhage. Natl Med J China. 2012;92(31):2202–4.
Beltramello A, Ricciardi GK, Piovan E, et al. Operative classification of brain arteriovenous malformation. Part two: validation. Interv Neuroradiol. 2009;15(3):266–74.
Cellerini M, Mangiafico S, Villa G, et al. Cerebral microarteriovenous malformations: diagnostic and therapeutic features in a series of patients. Am J Neuroradiol. 2002;23(6):945–52.
Dos Santos MLT, Demartini Z Jr, Matos LAD, et al. Angioarchitecture and clinical presentation of brain arteriovenous malformations. Arq Neuropsiquiatr. 2009;67(2 A):316–21.
Duong DH, Young WL, Vang MC, et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke. 1998;29(6):1167–76.
Hsieh SC, Liu HM. Angioarchitecture in predicting the bleeding risk of cerebral arteriovenous malformations. Chin J Radiol. 1999;24(6):223–6.
Ji Y, Ding X, Wang ZG. Analysis of relevant factors of cerebral arteriovenous malformation with hemorrhage. Natl Med J China. 2012;92(35):2488–90.
Kader A, Young WL, Pile-Spellman J, et al. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1994;34(5):801–8.
Kandai S, Abdullah MS, Naing NN. Angioarchitecture of brain arteriovenous malformations and the risk of bleeding: an analysis of patients in northeastern Malaysia. Malays J Med Sci. 2010;17(1):44–8.
Khaw AV, Mohr JP, Sciacca RR, et al. Association of infratentorial brain arteriovenous malformations with hemorrhage at initial presentation. Stroke. 2004;35(3):660–3.
Kubalek R, Moghtaderi A, Klisch J, Berlis A, Quiske A, Schumacher M. Cerebral arteriovenous malformations: influence of angioarchitecture on bleeding risk. Acta Neurochir. 2003;145(12):1045–52.
Kubalek R, Yin L, Fronhöfer G, Schumacher M. Cerebral arterio-venous malformations: correlation between the angioarchitecture and the bleeding risk. Arteriovenöse malformationen des gehirns: Einflüsse der angioarchitektur auf das blutungsrisiko. 2001;11(2):97–104.
Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King JT Jr. Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery. 1998;42(3):481–9.
Lv X, Wu Z, Jiang C, et al. Angioarchitectural characteristics of brain arteriovenous malformations with and without hemorrhage. World Neurosurg. 2011;76(1–2):95–9.
Marks MP, Lane B, Steinberg GK, Chang PJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology. 1990;176(3):807–13.
Mast H, Young WL, Koennecke HC, et al. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065–8.
Miyasaka Y, Kurata A, Irikura K, Tanaka R, Fujii K. The influence of vascular pressure and angiographic characteristics on haemorrhage from arteriovenous malformations. Acta Neurochir. 2000;142(1):39–43.
Miyasaka Y, Tanaka R, Kurata A, et al. The factors influencing haematoma volume due to arteriovenous malformations. Acta Neurochir. 1999;141(4):385–8.
Miyasaka Y, Yada K, Ohwada T, Kitahara T, Kurata A, Irikura K. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J Neurosurg. 1992;76(2):239–43.
Nataf F, Meder JF, Roux FX, et al. Angioarchitecture associated with haemorrhage in cerebral arteriovenous malformations: a prognostic statistical model. Neuroradiology. 1997;39(1):52–8.
Niu H, Cao Y, Wang X, et al. Relationships between hemorrhage, angioarchitectural factors and collagen of arteriovenous malformations. Neurosci Bull. 2012;28(5):595–05.
Pasqualin A. Natural history of cerebral AVM. Epidemiologia e storia naturale delle MAV cerebrali. 2002;15(1):29–40.
Pasqualin A, Barone G, Cioffi F, Rosta L, Scienza R, Da Pian R. The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations. Neurosurgery. 1991;28(3):370–9.
Pollock BE, Flickinger JC. A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg. 2002;96(1):79–85.
Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Factors that predict the bleeding risk of cerebral arteriovenous malformations. Stroke. 1996;27(1):1–6.
Spears J, TerBrugge KG, Moosavian M, et al. A discriminative prediction model of neurological outcome for patients undergoing surgery of brain arteriovenous malformations. Stroke. 2006;37(6):1457–64.
Stapf C, Mast H, Sciacca RR, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.
Stefani MA, Porter PJ, TerBrugge KG, Montanera W, Willinsky RA, Wallace MC. Angioarchitectural factors present in brain arteriovenous malformations associated with hemorrhagic presentation. Stroke. 2002;33(4):920–4.
Stiver SI, Ogilvy CS. Micro-arteriovenous malformations: significant hemorrhage from small arteriovenous shunts. Neurosurgery. 2000;46(4):811–9.
Vinuela F, Nombela L, Roach MR, Fox AJ, Pelz DM. Stenotic and occlusive disease of the venous drainage system of deep brain AVM's. J Neurosurg. 1985;63(2):180–4.
Yamada S, Takagi Y, Nozaki K, Kikuta KI, Hashimoto N. Risk factors for subsequent hemorrhage in patients with cerebral arteriovenous malformations. J Neurosurg. 2007;107(5):965–72.
Inci S, Ozcan OE, Benli K, Saatci I. Microsurgical removal of a free segment of microcatheter in the anterior circulation as a complication of embolization. Surg Neurol. 1996;46(6):562–6. Discussion 566–567.
Kallmes DF, McGraw JK, Evans AJ, et al. Thrombogenicity of hydrophilic and nonhydrophilic microcatheters and guiding catheters. AJNR Am J Neuroradiol. 1997;18(7):1243–51.
Partington CR, Graves VB, Rufenacht DA, et al. Biocompatibility of 1-French polyethylene catheters used in interventional neuroradiology procedures: a study with rats and dogs. AJNR Am J Neuroradiol. 1990;11(5):881–5.
Smith TP, Graves VB, Halbach VV, et al. Microcatheter retrieval device for intravascular foreign body removal. AJNR Am J Neuroradiol. 1993;14(4):809–11.
Altschul D, Paramasivam S, Ortega-Gutierrez S, Fifi JT, Berenstein A. Safety and efficacy using a detachable tip microcatheter in the embolization of pediatric arteriovenous malformations. Childs Nerv Syst. 2014;30(6):1099–107.
Paramasivam S, Altschul D, Ortega-Gutiarrez S, Fifi J, Berenstein A. N-butyl cyanoacrylate embolization using a detachable tip microcatheter: initial experience. J Neurointerv Surg. 2015;7(6):458–61.
Berthelsen B, Lofgren J, Svendsen P. Embolization of cerebral arteriovenous malformations with bucrylate. Experience in a first series of 29 patients. Acta Radiol. 1990;31(1):13–21.
Biondi A, Le Jean L, Capelle L, Duffau H, Marsault C. Fatal hemorrhagic complication following endovascular treatment of a cerebral arteriovenous malformation. Case report and review of the literature. J Neuroradiol. 2006;33(2):96–104.
Goto K, Uda K, Ogata N. Embolization of cerebral arteriovenous malformations (AVMs)—material selection, improved technique, and tactics in the initial therapy of cerebral AVMs. Neurol Med Chir (Tokyo). 1998;38(Suppl):193–9.
Inagawa S, Isoda H, Kougo H, Isogais S, Sakahara H. In-vitro simulation of NBCA embolization for arteriovenous malformation. Interv Neuroradiol. 2003;9(4):351–8.
Pile-Spellman J, Young WL, Joshi S, et al. Adenosine-induced cardiac pause for endovascular embolization of cerebral arteriovenous malformations: technical case report. Neurosurgery. 1999;44(4):881–6. Discussion 886–887.
Suh DC, Kim JH, Lee MS, et al. Penetration difference of n-butyl2-cyanoacrylate into the nidus in the embolisation of brain arteriovenous malformation. Interv Neuroradiol. 1998;4(1):63–74.
Tamatani S, Ito Y, Koike T, et al. Efficacy of diluted NBCA mixture for embolization of arteriovenous malformations. Interv Neuroradiol. 1999;5(Suppl 1):161–5.
Tamatani S, Koike T, Ito Y, Tanaka R. Embolization of arteriovenous malformation with diluted mixture of NBCA. Interv Neuroradiol. 2000;6(Suppl 1):187–90.
Goto K, Uda K, Ogata N. Improved technique for liquid embolization of cerebral arteriovenous malformation: catheter-tip position and flow control. J Clin Neurosci. 1998;5(Suppl):91–4.
Deruty R, Pelissou-Guyotat I, Mottolese C, et al. [Therapeutic risk in multidisciplinary approach of cerebral arteriovenous malformations]. Neurochirurgie. 1996;42(1):35–43.
Fahed R, Clarencon F, Sourour NA, et al. Rescue N-butyl-2 cyanoacrylate embolectomy using a Solitaire FR device after venous glue migration during arteriovenous malformation embolization: technical note. J Neurosurg. 2016;125(1):173–6.
Hademenos GJ, Massoud TF. Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment a theoretical analysis. Stroke. 1996;27(6):1072–83.
Hademenos GJ, Massoud TF. An electrical network model of intracranial arteriovenous malformations: analysis of variations in hemodynamic and biophysical parameters. Neurol Res. 1996;18(6):575–89.
Hademenos GJ, Massoud TF, Viñuela F. A biomathematical model of intracranial arteriovenous malformations based on electrical network analysis: theory and hemodynamics. Neurosurgery. 1996;38(5):1005–15.
Miyasaka Y, Kurata A, Tokiwa K, Tanaka R, Yada K, Ohwada T. Draining vein pressure increases and hemorrhage in patients with arteriovenous malformation. Stroke. 1994;25(2):504–7.
Norbash AM, Marks MP, Lane B. Correlation of pressure measurements with angiographic characteristics predisposing to hemorrhage and steal in cerebral arteriovenous malformations. Am J Neuroradiol. 1994;15(5):809–13.
Young WL, Kader A, Pile-Spellman J, et al. Arteriovenous malformation draining vein physiology and determinants of transnidal pressure gradients. Neurosurgery. 1994;35(3):389–96.
Willinsky R, Lasjaunias P, Terbrugge K, Pruvost P. Brain arteriovenous malformations: analysis of the angio-architecture in relationship to hemorrhage (based on 152 patients explored and/or treated at the hospital de Bicetre between 1981 and 1986). J Neuroradiol. 1988;15(3):225–37. MALFORMATIONS ARTERIO-VEINEUSES CEREBRALES. ANALYSE DE L'ANGIO-ARCHITECTURE CHEZ DES PATIENTS AYANT PRESENTE UN ACCIDENT HEMORRAGIQUE. REVUE DE 152 MALADES EXPLORES OU TRAITES A L'HOPITAL DE BICETRE ENTRE 1981 ET 1986.
Geibprasert S, Pongpech S, Jiarakongmun P, Shroff MM, Armstrong DC, Krings T. Radiologic assessment of brain arteriovenous malformations: what clinicians need to know. Radiographics. 2010;30(2):483–501.
Lasjaunias P, Manelfe C, Terbrugge K, Lopez Ibor L. Endovascular treatment of cerebral arteriovenous malformations. Neurosurg Rev. 1986;9(4):265–75.
Mansmann U, Meisel J, Brock M, Rodesch G, Alvarez H, Lasjaunias P. Factors associated with intracranial hemorrhage in cases of cerebral arteriovenous malformation. Neurosurgery. 2000;46(2):272–81.
Turjman F, Massoud TF, Sayre JW, Vinuela F, Guglielmi G, Duckwiler G. Epilepsy associated with cerebral arteriovenous malformations: a multivariate analysis of angioarchitectural characteristics. Am J Neuroradiol. 1995;16(2):345–50.
Batjer HH, Devous MD Sr. The use of acetazolamide-enhanced regional cerebral blood flow measurement to predict risk to arteriovenous malformation patients. Neurosurgery. 1992;31(2):213–7. Discussion 217–218.
Hassler W, Steinmetz H. Cerebral hemodynamics in angioma patients: an intraoperative study. J Neurosurg. 1987;67(6):822–31.
Merland JJ, Rufenacht D, Laurent A, Guimaraens L. Endovascular treatment with isobutyl cyano acrylate in patients with arteriovenous malformation of the brain. Indications, results and complications. Acta Radiolog Suppl. 1986;369:621–2.
Morgan MK, Sundt TM Jr. The case against staged operative resection of cerebral arteriovenous malformations. Neurosurgery. 1989;25(3):429–35. Discussion 435–426.
Vinters HV, Lundie MJ, Kaufmann JC. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate. N Engl J Med. 1986;314(8):477–83.
Young WL, Kader A, Prohovnik I, et al. Pressure autoregulation is intact after arteriovenous malformation resection. Neurosurgery. 1993;32(4):491–6. Discussion 496–497.
Young WL, Prohovnik I, Ornstein E, et al. The effect of arteriovenous malformation resection on cerebrovascular reactivity to carbon dioxide. Neurosurgery. 1990;27(2):257–66. Discussion 266–257.
Alexander MJ, Tolbert ME. Targeting cerebral arteriovenous malformations for minimally invasive therapy. Neurosurgery. 2006;59(5 Suppl 3):S178–83. Discussion S173–113.
Krings T, Hans FJ, Geibprasert S, Terbrugge K. Partial “targeted” embolisation of brain arteriovenous malformations. Eur Radiol. 2010;20(11):2723–31.
Le Feuvre D, Taylor A. Target embolization of AVMs: identification of sites and results of treatment. Interv Neuroradiol. 2007;13(4):389–94.
Settecase F, Hetts SW, Nicholson AD, et al. Superselective intra-arterial ethanol sclerotherapy of feeding artery and nidal aneurysms in ruptured cerebral arteriovenous malformations. AJNR Am J Neuroradiol. 2016;37(4):692–7.
Heidenreich JO, Hartlieb S, Stendel R, et al. Bleeding complications after endovascular therapy of cerebral arteriovenous malformations. AJNR Am J Neuroradiol. 2006;27(2):313–6.
Morgan MK, Johnston IH, Hallinan JM, Weber NC. Complications of surgery for arteriovenous malformations of the brain. J Neurosurg. 1993;78(2):176–82.
Young WL, Pile-Spellman J. Anesthetic considerations for interventional neuroradiology. Anesthesiology. 1994;80(2):427–56.
Mourier KL, Bellec C, Lot G, et al. Pyogenic parenchymatous and nidus infection after embolization of an arteriovenous malformation. An unusual complication. Case report. Acta Neurochir. 1993;122(1–2):130–3.
Sharma A, Jagetia A, Loomba P, Singh D, Tandon M. Delayed brain abscess after embolization of arterio-venous malformation: report of two cases and review of literature. Neurol India. 2011;59(4):620–3.
Ito M, Sonokawa T, Mishina H, Iizuka Y, Sato K. Disrupted and migrated microcatheter in the vertebrobasilar artery system in endovascular embolization of cerebellar AVM: failure of endovascular and microneurosurgical retrieval. J Clin Neurosci. 1998;5(Suppl):49–53.
Bingol H, Sirin G, Akay HT, Iyem H, Demirkilic U, Tatar H. Management of a retained catheter in an arteriovenous malformation. Case report. J Neurosurg. 2007;106(3):481–3.
Li T, Duan C, Wang Q, et al. Endovascular embolization of cerebral arteriovenous malformation. Zhonghua Yi Xue Za Zhi. 2002;82(10):654–6.
Li TL, Fang B, He XY, et al. Complication analysis of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate. Interv Neuroradiol. 2005;11(2):141–8.
Hetts S, Werne A, Hieshima GB. …and do no harm. AJNR Am J Neuroradiol. 1995;16(1):1–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Alexander, M.D., Cooke, D.L., Hetts, S.W. (2018). Treatment of Arteriovenous Malformations with Cyanoacrylate. In: Gandhi, C., Prestigiacomo, C. (eds) Cerebrovascular and Endovascular Neurosurgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65206-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-65206-1_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65204-7
Online ISBN: 978-3-319-65206-1
eBook Packages: MedicineMedicine (R0)